Buzzworthy developments of the past few days.

Technology leaders and academic researchers joined with healthcare professionals in Nigeria Nov. 13 to sketch out the future of African healthcare.

The product allows radiologists to zoom into breast cancer lesions and gather details on potential malignancy. 

The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”

A study looking at older Medicare beneficiaries in Texas highlights a need for targeted breast cancer screening outreach.

He has agreed to pay an administrative fee of $1,100 within the next three months.

Novo Nordisk shared initial results from the SELECT trial back in August, but now the full analysis—which includes data from more than 17,000 patients—has been published in The New England Journal of Medicine. 

Ramon Varcoe, MBBS, co-principal investigator for the LIFE-BTK trial, discussed the results with Cardiovascular Business at TCT 2023. "I can't wait to start using these in my patients. It's going to make a huge difference."

“We cannot emphasize strongly enough the depths of the departments’ failure," 25 members of the Ways & Means Committee wrote recently.

A radiologist unaffiliated with the campaign gave an impassioned speech on the topic, appealing to have the resolution presented for debate at the interim House of Delegates.